Gavreto

(pralsetinib)
Check Coverage Restrictions
Or select your Insurance from the list below:

Dosage & Administration

Select patients for treatment with GAVRETO based on the presence of a RET gene fusion.

The recommended dosage in adults and pediatric patients 12 years and older is 400 mg orally once daily on an empty stomach (no food intake for at least 2 hours before and at least 1 hour after taking GAVRETO).

Gavreto Prescribing Information

Gavreto Prior Authorization Resources

Benefits investigation

Gavreto Financial Assistance Options

Copay savings program

Bridge program

Foundation programs

Gavreto PubMed™ News

    Gavreto Patient Education

    Patient toolkit